Poolbeg Pharma advances POLB 001 into UK trial - ICYMI

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) CEO, Jeremy Skillington, talked with Proactive about recent progress alongside Principal Scientist Liam...